Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center

Addiction Clinical Trial

Official title:

Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02245685
• Other study ID #: BRD/07/07-M
• Status: Completed
• Phase: N/A
• First received: September 15, 2014
• Last updated: July 18, 2017
• Start date: January 2008
• Est. completion date: June 2014

Study information

• Verified date: July 2017
• Source: Nantes University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is part of the french priorities of the 2007-2011 addiction plan. Priority #2 of the plan underlines the need to improve practices and access to opioid substitution treatment. Priority 3 stresses the importance of articulation and coordination between specialized structures and community medicine to optimize the quality of care and to ensure continuity in the followup of these patients. This study focuses on the followup of patients under substitution therapy from the moment they enter a specialized care center for addicts to the period they are monitored by a general practitioner outside the specialized care center. The assessment described in this study should allow to harmonize and keep a continuity in patient monitoring.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 113
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients entering a specialized medical care center for addicts

Exclusion Criteria:

• Patients refusing to sign the consent for participation

Related Conditions & MeSH terms

• Addiction

Locations

Country	Name	City	State
France	CSST "La Rose des Vents"	Saint-Nazaire

Sponsors (2)

Lead Sponsor	Collaborator
Nantes University Hospital	French Health Products Safety Agency

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evolution of the severity score to heroin addiction (TMSP score)		From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Secondary	Evolution of the score of quality of life scale		From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Secondary	Evolution of the severity score to heroin addiction (TMSP score)		From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)
Secondary	Evolution of the score of quality of life scale		From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)